MSD CINV App at App Store analyse

App power index: 100 (based on ranks around App Stores today)
Health & Fitness
Developer: Ajit Shirodkar
Price: 0 free
Current version: 0.1, last update: 7 years ago
First release : 13 May 2015
App size: 2.52 Mb
4.8 ( 3728 ratings )
follow app

Estimation application downloads and cost

> 2.2k
Monthly downloads
~ $ 900
Estimation App Cost


Chemotherapy-induced nausea and vomiting (CINV) is one of the most feared side effects of cancer treatment1-3.Inadequately controlled emesis significantly impairs quality of life1.

e-MANAgE is a tool in the form of an App to guide physician in evaluating the emetogenecity level of chemotherapy (single/ combination) administered to their patients and in turn better management of CINV

The concept of the e-MANAgE is to provide a reliable method of predicting the risk of emesis following cancer chemotherapy.

This App is developed by MSD Pharmaceuticals Pvt. Ltd., India.


Copyright © 2015 MSD Pharmaceuticals Pvt. Ltd.,
a subsidiary of Merck Sharp & Dohme Corp.,
Whitehouse Station, N.J., U.S.A. All rights reserved.
ONCO-1142625-0000 25/02/2015 24/02/2016


Reference:
1) Hesketh PJ. Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice. Oncologist. 1999;4(3):191-6.

2) Coates A, Abraham S, Kaye SB, et al. On the receiving end: patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol. 1983;19(2):203-8.

3) Griffin AM, Butow PN, Coates AS, et al. On the receiving end V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol. 1996;7(2):189-95.
Read more
No search terms founded
Available in countries
Country Price
USA free
Available for devices
iPhone3GS, iPhone4, iPodTouchFourthGen, iPad2Wifi, iPad23G, iPhone4S, iPadThirdGen, iPadThirdGen4G, iPhone5, iPodTouchFifthGen, iPadFourthGen, iPadFourthGen4G, iPadMini, iPadMini4G, iPhone5c, iPhone5s, iPadAir, iPadAirCellular, iPadMiniRetina, iPadMiniRetinaCellular, iPhone6, iPhone6Plus, iPadAir2, iPadAir2Cellular, iPadMini3, iPadMini3Cellular, iPodTouchSixthGen, iPhone6s, iPhone6sPlus, iPadMini4, iPadMini4Cellular, iPadPro, iPadProCellular, iPadPro97, iPadPro97Cellular, iPhoneSE,